About this document

GLP-1 Therapies for Type 2 Diabetes Management by Ridha Surya Nugraha is a document available to read on EtoBox.

The document summarizes clinical trial results of several GLP-1 related agents for the treatment of type 2 diabetes. It finds that: 1) Liraglutide, a GLP-1 analog, significantly reduced A1c levels compared to placebo and was associated with mild side effects and no weight gain. 2) CJC-1131, another GLP-1 analog, was associated with an average 1.1% greater reduction in A1c levels compared to placebo and mean weight loss. 3) Vildagliptin, a DPP-IV inhibitor, significantly decreased A1c levels compared to

Author

Ridha Surya Nugraha

Language

EN